Michael N. Liebman is a leading scientist in the field of biomedical informatics. His research focuses on computational models of disease progression stressing risk detection, disease process and pathway modeling and analysis of lifestyle interactions...
'Although lack of efficacy is an important cause of late stage attrition in drug development the shortcomings in the translation of toxicities observed during the preclinical development to observations in clinical trials or post-approval is an ongoing topic of research.'
‘A key aspect of realizing the full potential of database interoperability is to promote the use of consistent terminology and “cross-walk” approaches for addressing the different terminologies already in use.’
Jaclyn N. Taroni